SightfileU.S. market data from official filings

INDIVIOR PHARMACEUTICALS INC (INDV)

Name: INDIVIOR PHARMACEUTICALS INC (INDV) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001625297 · EDGAR filings · Updated 2026-07-13

INDIVIOR PHARMACEUTICALS INC (INDV) has reported institutional ownership of 104.6%, with 289 institutional managers holding positions valued at $3.89B per the latest 13F reporting period.

Institutional ownership

104.6%

Institutional managers

289

Reported 13F value

$3.89B

Insider activity

33 trans.

$203.6K net buying

Latest updates

2026-07-13 — Insider transaction reported (Form 4)
2026-07-10 — Notice of proposed sale filed (Form 144)
2026-06-23 — Insider transaction reported (Form 4)
2026-06-12 — Insider transaction reported (Form 4)
2026-06-11 — Notice of proposed sale filed (Form 144)
2026-06-10 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, INDIVIOR PHARMACEUTICALS INC has 289 institutional holders and institutional ownership of 104.6%.

Insider activity

Insiders reported 33 transactions (8 buys, 0 sells) across 13 reporting insiders, with a net reported value of $203.6K.

Related companies

LIGAND PHARMACEUTICALS INC (LGND) · Newamsterdam Pharma Co NV (NAMS) · SOTERA HEALTH CO (SHC) · TANGO THERAPEUTICS INC (TNGX) · LIVANOVA PLC SHS (LIVN) · EDGEWISE THERAPEUTICS INC (EWTX)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-13.